Vincenzo Musolino is an expert in Biochemistry at Magna Graecia University (Italy). Vincenzo Musolino has authored 119 publications, the most recent in 2026. SLR score: 310 (community average: 125). How the SLR is computed.

LeadR Profile

Vincenzo Musolino Magna Graecia University Italy
310 ScienceLeadR Reputation 310
Network Map

Biochemistry

Subspecialties: Pharmacy - Nutrition - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2026

Source: PubMed

Magna Graecia University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 119

Citations

Citations: 3 332 1st author: 12 Last author: 1 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
In vitro, ex vivo and in vivo evaluation of polyelectrolyte nanogels for mucosal vaccines.
PMID 42875718 — nanogels, vaccines, macrophages, administration, intranasal, immunity, mucous membrane, polyelectrolytes, lysine
Drug Deliv Transl Res20260
The role of Bergamot Polyphenolic Fraction (BPF) in MASLD-Induced HFpEF: Mitigate diastolic dysfunction by targeting chronic low-grade inflammation.
PMID 40695041 — heart failure, diastolic, drug therapy, diet, research, therapeutics
Biomed Pharmacother20254
Efficacy of meglumine antimoniate treatment on boxer Leishmania infantum skin lesions: case report.
PMID 40661166 — injections, skin, meglumine, meglumine antimoniate, blood, leishmaniasis, cutaneous, diagnosis, therapeutics, leishmaniasis, wounds and injuries, injections, subcutaneous
Front Vet Sci20250
Current Findings on Allium Species with Melanogenesis Inhibitory Activity.
PMID 40508310 — skin, monophenol monooxygenase, dermatology, phytochemicals
Plants (Basel)20250
Modulation of GLP-1 signalling as an innovative strategy counteracting the onset of heart failure: Potential for natural compound supplementation.
PMID 40268125 — glucagon-like peptide 1, heart failure, heart, pharmacology
Pharmacol Res20250

LeadR Networks

Main global connection map